Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Townelong as BACs and site-directed mutagenesis using a PCR-based technique

Virology

Volumn 307, Issue 1, 2003, Pages 164-177

  Hahn, Gabriele ^a   Rose, Dietlind ^a   Wagner, Markus ^a   Rhiel, Sylvia ^a   McVoy, Michael A ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE DELETION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0037347208     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00061-2     Document Type: Article

References (49)

1. Adler H., Messerle M., Wagner M., Koszinowski U.H. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74:2000;6964-6974.
2. Bolovan-Fritts C., Wiedeman J.A. Human cytomegalovirus strain Toledo lacks a virus-encoded tropism factor required for infection of aortic endothelial cells. J. Infect. Dis. 184:2001;1252-1261.
3. Borst E.M., Hahn G., Koszinowski U.H., Messerle M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli a new approach for construction of HCMV mutants . J. Virol. 73:1999;8320-8329.
4. Brown J.M., Kaneshima H., Mocarski E.S. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J. Infect. Dis. 171:1995;1599-1603.
5. Cha T.A., Tom E., Kemble G.W., Duke G.M., Mocarski E.S., Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:1996;78-83.
6. Chee M.S., Bankier A.T., Beck S., Sohni R., Brown C.M., Cerny R., Horsnell T., Hutchinson C.A., Kouzarides T., Marignetti J.A., Preddie E., Satchwell S.C., Tomlinson P., Weston K., Barrell B.G. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Dougall J.K. Cytomegaloviruses. Vol. 154:1990;125-169 Springer-Verlag, New York.
7. Dargan D.J., Jamieson F.E., MacLean J., Dolan A., Addison C., McGeoch D.J. The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J. Virol. 71:1997;9833-9836.
8. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA. 97:2000;6640-6645.
9. Delecluse H.J., Hilsendegen T., Pich D., Zeidler R., Hammerschmidt W. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. USA. 95:1998;8245-8250.
10. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326:1992;663-667.
11. Gerna G., Percivalle E., Baldanti F., Revello M.G. Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. J. Med. Virol. 66:2002;335-339.
12. Gerna G., Percivalle E., Sarasini A., Revello M.G. Human cytomegalovirus and human umbilical vein endothelial cells restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation . J. Clin. Microbiol. 40:2002;233-238.
13. Gonczol E., Plotkin S. Development of a cytomegalovirus vaccine lessons from recent clinical trials . Expert. Opin. Biol. Ther. 1:2001;401-412.
14. Greaves R.F., Brown J.M., Vieira J., Mocarski E.S. Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen. Virol. 76:1995;2151-2160.
15. Grundy J.E., Lawson K.M., MacCormac L.P., Fletcher J.M., Yong K.L. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J. Infect. Dis. 177:1998;1465-1474.
16. Hahn G., Jores R., Mocarski E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA. 95:1998;3937-3942.
17. Hahn G., Khan H., Baldanti F., Koszinowski U.H., Revello G.M., Gerna G. The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells as determined by a BAC cloned clinical isolate of HCMV with preserved wild-type characteristics. J. Virol. 76:2002;9551-9555.
18. Hobom U., Brune W., Messerle M., Hahn G., Koszinowski U.H. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes mutational analysis of human cytomegalovirus envelope glycoprotein genes . J. Virol. 74:2000;7720-7729.
19. Horsburgh B.C., Hubinette M.M., Qiang D., MacDonald M.L., Tufaro F. Allele replacement An application that permits rapid manipulation of herpes simplex virus type 1 genomes . Gene Ther. 6:1999;922-930.
20. Kondo K., Xu J., Mocarski E.S. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA. 93:1996;11137-11142.
21. MacCormac L.P., Grundy J.E. Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne, or Davis strains. J. Med. Virol. 57:1999;298-307.
22. Marchini A., Liu H., Zhu H. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:2001;1870-1878.
23. McGregor A., Schleiss M.R. Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli. Mol. Genet. Metab. 72:2001;15-26.
24. McVoy M.A., Adler S.P. Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J. Virol. 68:1994;1040-1051.
25. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., Koszinowski U.H. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA. 94:1997;14759-14763.
26. Mocarski E.S. Cytomegaloviruses and their replication. Fields B.M., Knipe D.M., Howley P.M. Fields Virology. 3rd ed:1996;2447-2492 Lippincott-Raven Publishers, Philadelphia.
27. Mocarski E.S., Bonyhadi M., Salimi S., McCune J.M., Kaneshima H. Human cytomegalovirus in a SCID-hu mouse thymic epithelial cells are prominent targets of viral replication . Proc. Natl. Acad. Sci. USA. 90:1993;104-108.
28. Mocarski E.S., Liu A.C., Spaete R.R. Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J. Gen. Virol. 68:1987;2223-2230.
29. Mocarski E.S., Prichard M.N., Tan C.S., Brown J.M. Reassessing the organization of the UL42-43 region of the human cytomegalovirus strain AD169 genome. Virology. 239:1997;169-175.
30. Muyrers J.P., Zhang Y., Stewart A.F. ET-cloning think recombination first . Genet. Eng. (NY). 22:2000;77-98.
31. Plotkin S.A., Andre F., Poolman J., Robbins J., Salisbury D., Wood D. Preclinical and clinical development of new vaccines. Biologicals. 26:1998;247-251.
32. Plotkin S.A., Farquhar J., Hornberger E. Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J. Infect. Dis. 134:1976;470-475.
33. Plotkin S.A., Friedman H.M., Fleisher H.M., Dafoe D.C., Grossman R.A., Smiley M.L., Starr S.E., Wlodaver C., Friedman A.D., Barker C.F. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet. i:1984;528-530.
34. Prichard M.N., Penfold M.E., Duke G.M., Spaete R.R., Kemble G.W. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11:2001;191-200.
35. Revello M.G., Percivalle E., Arbustini E., Pardi R., Sozzani S., Gerna G. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J. Clin. Invest. 101:1998;2686-2692.
36. Riegler S., Hebart H., Einsele H., Brossart P., Jahn G., Sinzger C. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen. Virol. 81:2000;393-399.
37. Saeki Y., Ichikawa T., Saeki A., Chiocca E.A., Tobler K., Ackermann M., Breakefield X.O., Fraefel C. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli rescue of replication-competent virus progeny and packaging of amplicon vectors . Hum. Gene Ther. 9:1998;2787-2794.
38. Shizuya H., Birren B., Kim U.J., Mancino V., Slepak T., Tachiiri Y., Simon M. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA. 89:1992;8794-8797.
39. Sinzger C., Grefte A., Plachter B., Gouw A.S., The T.H., Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76:1995;741-750.
40. Sinzger C., Schmidt K., Knapp J., Kahl M., Beck R., Waldman J., Hebart H., Einsele H., Jahn G. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 80:1999;2867-2877.
41. Skaletskaya A., Bartle L.M., Chittenden T., McCormick A.L., Mocarski E.S., Goldmacher V.S. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA. 98:2001;7829-7834.
42. Smith G.A., Enquist L.W. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 73:1999;6405-6414.
43. Smith G.A., Enquist L.W. A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc. Natl. Acad. Sci. USA. 97:2000;4873-4878.
44. Soderberg-Naucler C., Streblow D.N., Fish K.N., Allan-Yorke J., Smith P.P., Nelson J.A. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J. Virol. 75:2001;7543-7554.
45. Stinski M.F. Cytomegalovirus and its replication. Fields B.N., Knipe D.N. Fundamental Virology. 2nd ed:1991;929-950 Raven Press, New York.
46. Tamashiro J.C., Spector D.H. Terminal structure and heterogeneity in human cytomegalovirus strain AD169. J. Virol. 59:1986;591-604.
47. Wagner M., Jonjic S., Koszinowski U.H., Messerle M. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:1999;7056-7060.
48. Wagner M., Ruzsics Z., Koszinowski U.H. Herpesvirus genetics has come of age. Trends Microbiol. 10:2002;318-324.
49. Yu D., Smith G.A., Enquist L.W., Shenk T. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76:2002;2316-2328.